Deliver Your News to the World

Parkinsonís Drug Market receives Infusion Of Cash


(Springfield, GA)óA San Diego drug maker is hoping an infusion of research capital will allow it to continue its work in searching for Parkinsonís disease treatments.

Acadia Pharmaceuticals, which hopes its drug, pimavanserin, will treat Parkinsonís-related psychosis, recently received $30 million from Canadian pharmaceuticals company Biovail Corp. in a deal that could see additional investment should the drug succeed during current trials. According to one Parkinsonís advocate, even more should be done.

ďWhile increased research money from pharmaceutical companies is great,Ē says author and advocate Kay Mixson Jenkins, ďwe need more federal support and a greater push from the leaders at the state level to fund research.Ē

Ms. Jenkins is the author of Who Is Pee Dee? Explaining Parkinsonís Disease to a Child, which tells the story of a young boy named Colt, who is trying to deal with his motherís illness. Colt is helped by his toy bear, Pee Dee.

ďI hope that the book builds awareness of how Parkinsonís affects families all over the world,Ē says Ms. Jenkins. ďMaybe that exposure will create a push from the public for more funding.Ē

Ms. Jenkins, a longtime advocate for Parkinsonís research and the founder of the non-profit organization Parkinsonís in the Park, uses Who Is Pee Dee? to illustrate the following:

ē Without medications like those being tested by Acadia, parents with Parkinsonís are sometimes unable to parent.
ē Parkinsonís patients suffer from the side effects of these medications.
ē Parkinsonís patients need love and support in addition to medication.
ē Parkinsonís affects everyone around the patient.

ďI hope that companies like Acadia can deliver on their potential,Ē says Ms. Jenkins.

For more information, contact the author directly via

(Who Is Pee Dee? Explaining Parkinsonís Disease to a Child by Kay Mixson Jenkins; illustrated by Richard Morgan; ISBN: 978-0-9819129-0-5; $12.95; 33 pages; 8Ē x 8Ē; hardcover; UCB, Inc.)


 Parkinsonís disease
 Parkinsonís In The Park
 living with Parkinsonís
 childrenís book Parkinson
 family and Parkinsonís

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.